Keyphrases
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
90%
Systolic Blood Pressure Intervention Trial (SPRINT)
37%
Chronic Kidney Disease
29%
Polycystic Kidney Disease
25%
Systolic Blood Pressure
24%
Hypertension
23%
Kidney Stones
19%
Kidney
18%
Kidney Disease Progression
17%
Dual-energy Computed Tomography
15%
Estimated Glomerular Filtration Rate
14%
Cardiovascular Outcomes
14%
Confidence Interval
13%
Tolvaptan
13%
Acute Kidney Injury
13%
Kidney Disease
12%
Blood Pressure Control
12%
Peritoneal Dialysis Patients
12%
Total Kidney Volume
11%
Hypertension Management
11%
Left Ventricular Mass
11%
Magnetic Resonance Imaging
10%
Kidney Failure
10%
Urinary Calculi
10%
Cyst
10%
Peritoneal Dialysis
9%
Blood Pressure
8%
Hazard Ratio
8%
Proteinuria
8%
Computed Tomography
8%
Hypertensive Patients
8%
Kidney Function
8%
Rituximab
8%
Dual-energy CT
8%
Membranous Nephropathy
7%
Kidney Cyst
7%
Treatment Group
7%
Intracranial Aneurysm
7%
Risk Factors
7%
Diastolic Blood Pressure
7%
Randomized Clinical Trial
7%
Polycystic Liver Disease
7%
Left Ventricular Hypertrophy
7%
End-stage Renal Disease
7%
Clinical Trials
6%
Polycystin
6%
Disease-modifying Therapy
6%
Nephrologists
6%
Systemic Hypertension
6%
COL4A1
6%
Phantom Study
6%
Novel Variants
6%
Ambulatory Blood Pressure
6%
Ultrashort Echo Time
6%
Intensive Care Medicine
6%
Cardiovascular Risk
6%
Stone Composition
6%
24-h Ambulatory Blood Pressure Monitoring
6%
Intensive Blood Pressure
6%
Renal Transplant Recipients
5%
PKD1
5%
Stone Formers
5%
Albuminuria
5%
Kidney Transplantation
5%
Kidney Function Decline
5%
Dialysis
5%
Clinical Practice Guidelines
5%
PKD2
5%
Radiation Exposure
5%
Optimal Treatment
5%
Monogenic
5%
Treatment Study
5%
Hemodialysis
5%
Albumin-to-creatinine Ratio
5%
Adverse Events
5%
Tubular Injury
5%
Blood Pressure Target
5%
Phospholipase A2 Receptor (PLA2R)
5%
Blood Pressure Variability
5%
Blood Pressure Treatment
5%
Body Mass Index
5%
Essential Hypertension
5%
Patient Characteristics
5%
End-stage Kidney Disease
5%
Dual-source Dual-energy CT
5%
Tubular Cells
5%
Medicine and Dentistry
Polycystic Kidney Disease
100%
Chronic Kidney Disease
38%
Kidney Stone
33%
Systolic Blood Pressure
27%
Kidney Function
24%
Intervention Trial
22%
Blood Pressure
20%
Glomerular Filtration Rate
18%
Diseases
18%
Dual Energy Computed Tomography
18%
Nephropathy
17%
Peritoneal Dialysis
17%
Biological Marker
15%
Cardiovascular System
15%
Magnetic Resonance Imaging
14%
Prevalence
14%
Creatinine
14%
Renal Failure
13%
Urinary System
13%
Tolvaptan
12%
End Stage Renal Disease
11%
Hemodialysis
11%
Acute Kidney Injury
10%
Urolithiasis
9%
Proteinuria
9%
Kidney Graft
9%
Computer Assisted Tomography
8%
Disease Exacerbation
8%
Infection
7%
Blood Pressure Monitoring
7%
Renal Cyst
7%
Liver Polycystic Disease
7%
Nephrologist
7%
Cardiovascular Disease
7%
Intracranial Aneurysm
7%
Genetic Screening
6%
Rituximab
6%
Pressure Control
6%
Membranous Glomerulonephritis
6%
Essential Hypertension
6%
Randomized Controlled Trial
6%
Hazard Ratio
6%
Renal Replacement Therapy
6%
Albumin
6%
Adverse Event
6%
Interstitial Nephritis
6%
Kidney Transplantation
6%
Nephrology
6%
PKD1
5%
Glomerulonephritis
5%
Glomerulopathy
5%
Oxalic Acid
5%
Radiation Exposure
5%
Arm
5%
Body Mass Index
5%
Renal Biopsy
5%
In Vitro
5%